Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Bay Area's Ardelyx Nabs $160M Deal With Kyowa Hakko Kirin

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:BioPharma

Ardelyx will receive a $30 million upfront payment and is eligible to receive additional development and commercialization milestones worth up to $130 million. Source: BioSpace

Continue ReadingBay Area's Ardelyx Nabs $160M Deal With Kyowa Hakko Kirin

Clovis Expands Bay Area Footprint With Huge Lease in Oakland

  • Post author:Sam
  • Post published:November 27, 2017
  • Post category:BioPharma

Clovis Oncology has solidified its physical footprint in the Bay Area with a 32,000 square foot space it secured for 10 years through property developer TMG Partners. Source: BioSpace

Continue ReadingClovis Expands Bay Area Footprint With Huge Lease in Oakland

Qiagen Plans to Create Up to 800 Jobs at New UK Campus Post Brexit

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Qiagen's investment will be an expansion of its current operations in that northern England city. Source: BioSpace

Continue ReadingQiagen Plans to Create Up to 800 Jobs at New UK Campus Post Brexit

Merck Plots 950-Job R&D Hub in London

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

The move is in part related to Brexit, the UK's exit from the European Union. Source: BioSpace

Continue ReadingMerck Plots 950-Job R&D Hub in London

3 Top Diabetes Biotechs to Buy Into Right Now

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Diabetes is huge problem for Americans. Source: BioSpace

Continue Reading3 Top Diabetes Biotechs to Buy Into Right Now

Why Shire Should Spin Off Its Neuroscience Biz and Merge With This Maryland Pharma

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Kenneth Pittman, writing for Seeking Alpha, takes a look at why Shire is thinking of unloading its neuroscience division and suggesting an alternative. Source: BioSpace

Continue ReadingWhy Shire Should Spin Off Its Neuroscience Biz and Merge With This Maryland Pharma

AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

The deal aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the country. Source: BioSpace

Continue ReadingAstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company

Innate Tanked as Drug Combined With Bristol-Myers' Opdivo Flopped in Study

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

While lirilumab was shown to be well-tolerated, it did not demonstrate efficacy in treating that patient population. Source: BioSpace

Continue ReadingInnate Tanked as Drug Combined With Bristol-Myers' Opdivo Flopped in Study

Teva Expected to Fire Up to 1,700 Workers in Israel, U.S.

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

News of the layoffs comes hard on the heels of the company's credit rating having been cut to junk status by Fitch Rating. Source: BioSpace

Continue ReadingTeva Expected to Fire Up to 1,700 Workers in Israel, U.S.

Teva Shakes Up C-Suite in Restructuring

  • Post author:Sam
  • Post published:November 26, 2017
  • Post category:BioPharma

Since taking over at Teva earlier this fall, Kare Schultz has been swiftly moving to shore up the finances and pay down the massive debts of the beleaguered pharmaceutical company.…

Continue ReadingTeva Shakes Up C-Suite in Restructuring
  • Go to the previous page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.